1. Home
  2. |Insights
  3. |DEAL NOTE: Crowell & Moring Represents Kountable in Series A-1 Financing Lead by Lateral Capital

DEAL NOTE: Crowell & Moring Represents Kountable in Series A-1 Financing Lead by Lateral Capital

Firm News | 1 min read | 02.10.21

San Francisco – February 10, 2021: Crowell & Moring advised Kountable Inc., the leading global trade and technology platform, in connection with its Series A-1 financing lead by Lateral Capital. Kountable secured this round of funding as part of its efforts to expand its U.S. presence and widen its COVID response to further support small and medium-sized enterprises (SMEs). The Kountable platform operates as the necessary missing element that gets critical goods delivered in difficult market conditions. For the past five years, Kountable has activated the capability of SMEs through is curated execution network to efficiently complete large scale projects for governments, foundations, NGOs, and corporations that have had a positive impact on millions of lives. Kountable has solved the challenges of collaboration between critical but overlooked SMEs who play a key role in the success of vast swaths of global trade activity, global multinational suppliers, funders, and logistics and trade services providers.

Kountable will use the strategic capital to scale its business in global healthcare supply chains, specifically in connection with the pandemic response. The funding investment will further enhance its trade and treasury cloud platform, as well as launch its long-anticipated membership offering within the U.S. that will particularly focus on supplier diversity programs and inclusive supply chains. Kountable’s current presence includes offices in San Francisco, Nairobi, Kigali, and The Hague.

Crowell & Moring served as lead counsel to Kountable in this transaction. The team included partners Jon O'Connell and Olivia Lynch, senior counsels Mark Kass and Scott Lessne, and counsel Steven Ryan.

Insights

Firm News | 2 min read | 05.22.26

Crowell & Moring Represents Kanders & Company in Acquisition of Ginkgo Bioworks’ Biosecurity Business

May 22, 2026: A Crowell & Moring team represented Kanders & Company in a complex carveout transaction in which Kanders acquired the biosecurity business of publicly traded Ginkgo Bioworks. The resulting company, Perimeter Systems, has launched as the world’s first integrated biosecurity infrastructure platform, designed to transform biological signals into real-time intelligence and accelerate decisive response. At closing, Perimeter secured $60 million in growth capital, led by Kanders in partnership with SCS Financial, Goldcrest Capital, Four Cities Capital, and the Safe Artificial Intelligence Fund (SAIF)....